Literature DB >> 27755783

Evaluation on the incidence, mortality and tendency of lung cancer in China.

Wanqing Chen1, Siwei Zhang1, Xiaonong Zou1.   

Abstract

OBJECTIVE: To analyze lung cancer epidemiological trends and estimate the lung cancer burden in China.
METHODS: The age-specific mortality/incidence ratios in different geographical areas and for both sexes for lung cancer were obtained from the National Cancer Registration database in 2004 and 2005. Cancer crude mortality rates were retrieved from the database of the third national death survey from 2004-2005. Age-specific incidence rates of lung cancer were calculated using mortality and mortality/incidence ratios. The annual percent change was estimated with a log regression model using joinpoint software analyzing pooled lung cancer incidence data from 10 cancer registries from 1988 to 2005.
RESULTS: The total estimated new lung cancer cases and deaths in 2005 were 536 407 and 475 768 respectively, the numbers were higher for men than for women, and show an increase of 1.63% annually from 1988 to 2005. However, the trend showed a slowdown of 0.55% after being adjusted for age.
CONCLUSIONS: Lung cancer is one of the major health issues in China and the burden is getting serious. Aging is the main cause for the increasing incidence and mortality of lung cancer. Effective cancer prevention and control is imperative. Tobacco control especially should be implemented in nationwide. © Tianjin Lung Cancer Institute and Blackwell Publishing Asia Pty. Ltd.

Entities:  

Keywords:  Cancer registry; China; epidemiology; incidence; lung cancer; mortality

Mesh:

Year:  2010        PMID: 27755783     DOI: 10.1111/j.1759-7714.2010.00011.x

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


  20 in total

1.  Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.

Authors:  T Wang; T Chen; A Thakur; Y Liang; L Gao; S Zhang; Y Tian; T Jin; J J Liu; M Chen
Journal:  Clin Transl Oncol       Date:  2015-03-06       Impact factor: 3.405

2.  Case-Control Study on Impact of the Telomerase Reverse Transcriptase Gene Polymorphism and Additional Single Nucleotide Polymorphism (SNP)- SNP Interaction on Non-Small Cell Lung Cancers Risk in Chinese Han Population.

Authors:  Yan-Li Xing; Feng Liu; Jian-Feng Li; Jian-Cong Lin; Guo-Dong Zhu; Ming Li; Chang-Ran Zhang; Yuan-Yuan Niu
Journal:  J Clin Lab Anal       Date:  2016-05-07       Impact factor: 2.352

3.  Gender disparities in incidence and projections of lung cancer in China and the United States from 1978 to 2032: an age-period-cohort analysis.

Authors:  Min Jiang; Cairong Zhu; Minghan Xu; Mandi Li; Jiao Pei; Chenyao Wu; Lin Jiang
Journal:  Cancer Causes Control       Date:  2022-08-02       Impact factor: 2.532

4.  Genetic variation in the TP63 gene is associated with lung cancer risk in the Han population.

Authors:  Qun-Ying Hu; Tian-Bo Jin; Li Wang; Le Zhang; Tingting Geng; Guinian Liang; Long-Li Kang
Journal:  Tumour Biol       Date:  2013-10-04

5.  Induction of G2/M phase arrest and apoptosis by ZGDHU-1 in A549 and RERF-LC-MA lung cancer cells.

Authors:  Xinfeng Shen; Zhen Wu; Sufeng Chen; Yu Chen; Jun Xia; Yaping Lv; Yonglie Zhou
Journal:  Oncol Lett       Date:  2016-06-09       Impact factor: 2.967

6.  An elderly patient with advanced lung cancer achieved long-term survival using Chinese medicine: An alternative treatment strategy for cancer patients aged 80 or older without a tissue confirmed diagnosis.

Authors:  Rui Liu; Shu-Lin He; Yoshiro Hirasaki; Hong-Gang Zheng; Bao-Jin Hua
Journal:  Chin J Integr Med       Date:  2015-11-23       Impact factor: 1.978

7.  TERT rs2736100T/G polymorphism upregulates interleukin 6 expression in non-small cell lung cancer especially in adenocarcinoma.

Authors:  Fuxia Wang; Ping Fu; Yixin Pang; Chengxiang Liu; Zhulin Shao; Jingyan Zhu; Jie Li; Ti Wang; Xia Zhang; Jie Liu
Journal:  Tumour Biol       Date:  2014-01-14

8.  Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.

Authors:  Jihua Yang; Shunchang Jiao
Journal:  Tumour Biol       Date:  2014-03-04

9.  Correlation of CLPTM1L polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a Chinese Han population.

Authors:  Yiqian Liang; Asmitananda Thakur; Lei Gao; Ting Wang; Shuo Zhang; Hui Ren; Junhui Meng; Tingting Geng; Tianbo Jin; Mingwei Chen
Journal:  Tumour Biol       Date:  2014-08-26

10.  CLPTM1L genetic polymorphisms and interaction with smoking and alcohol drinking in lung cancer risk: a case-control study in the Han population from northwest China.

Authors:  Xiaojie Xun; Huijuan Wang; Hua Yang; Hong Wang; Bo Wang; Longli Kang; Tianbo Jin; Chao Chen
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.